Cargando…
A Retrospective Exploration of Targeted Maintenance Therapy in Advanced Colorectal Cancer: Based on the Background of Chinese Patient Assistance Program
Background: Maintenance therapy with bevacizumab (Bev) in patients with colorectal cancer (CRC) provides progression-free survival (PFS) benefits. However, the role of maintenance therapy with an anti-EGFR monoclonal antibody has not been established. Methods: Eligible CRC patients were assigned to...
Autores principales: | Hu, Hanguang, Liu, Xue, Cai, Wen, Wu, Dehao, Xu, Junxi, Yuan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190810/ https://www.ncbi.nlm.nih.gov/pubmed/32391263 http://dx.doi.org/10.3389/fonc.2020.00522 |
Ejemplares similares
-
Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study
por: Cai, Wen, et al.
Publicado: (2021) -
EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs
por: Cai, Wen, et al.
Publicado: (2018) -
Efficacy, safety and predictors of combined fruquintinib with programmed death-1 inhibitors for advanced microsatellite-stable colorectal cancer: A retrospective study
por: Zhang, Weijie, et al.
Publicado: (2022) -
Editorial: Advances in and Application of Robotic-Assisted Surgery for Colorectal Cancer
por: Chen, Po-Jung, et al.
Publicado: (2021) -
A novel 4-gene prognostic signature for hypermutated colorectal cancer
por: Ge, Weiting, et al.
Publicado: (2019)